Novel Challenges and Advances in Extracorporeal Membrane Oxygenation (ECMO)
A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Personalized Critical Care".
Deadline for manuscript submissions: 20 October 2024 | Viewed by 56
Special Issue Editor
Interests: cardiovascular medicine; personalized medicine; artificial intelligence; multidisciplinary team care; heart failure
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Extracorporeal Membrane Oxygenation (ECMO) has emerged as a critical technology for managing severe respiratory and cardiac failure. This Special Issue aims to highlight the latest advancements in ECMO technology, including clinical applications, patient outcomes, and future research directions.
The topics covered include novel ECMO circuit designs, ECMO in various clinical scenarios, such as ARDS and cardiogenic shock, hemocompatibility, and anticoagulation strategies, ECMO in pediatric and neonatal populations, the lessons learned from ECMO use in COVID-19 patients, ECMO as a bridge to transplantation, ECMO in trauma and ECPR, the management of neurological complications in ECMO patients, and the long-term outcomes of ECMO survivors.
Authors are encouraged to submit original research articles, reviews, and clinical studies related to ECMO. Submissions will undergo rigorous peer review, adhering to the journal's formatting guidelines.
We invite contributions from researchers, clinicians, and experts in ECMO to share insights and advancements, ultimately aiming to improve patient outcomes and expand the applications of this life-saving technology.
Dr. Michalina Kołodziejczak
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- extracorporeal Membrane Oxygenation (ECMO)
- respiratory failure
- cardiac failure
- ARDS
- cardiogenic shock
- COVID-19
